Lazard Asset Management »

Supernus Pharmaceuticals shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $344k 12k 28.68
2023-09-30 $327k 12k 27.47
2023-06-30 $132k 4.4k 30.02
2022-12-31 $62k 1.7k 35.47
2022-09-30 $59k 1.7k 33.75
2022-06-30 $101k 3.5k 28.87
2022-03-31 $65k 2.0k 31.89
2021-12-31 $59k 2.0k 29.15
2021-09-30 $46k 1.8k 26.29
2021-06-30 $59k 1.9k 30.57
2021-03-31 $50k 1.9k 25.91
2020-09-30 $51k 2.5k 20.72
2019-12-31 $54k 2.3k 23.64
2019-09-30 $12k 463 25.92
2018-06-30 $2.0M 34k 59.82
2018-03-31 $1.5M 34k 45.79
2017-12-31 $1.4M 35k 39.83
2017-09-30 $2.1M 54k 40.00
2017-06-30 $2.8M 64k 43.09
2017-03-31 $2.1M 66k 31.29
2016-12-31 $3.6M 143k 25.25
2016-09-30 $3.5M 143k 24.72
2016-06-30 $2.9M 143k 20.37